Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Identify index funds with the lowest expense ratios for retirement and understand how fees impact long-term savings and withdrawals.
27,234 articlesA bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Microsoft stands at the crossroads of cloud infrastructure and productivity software, offering a durable growth thesi...
As policy moves accelerate quantum adoption, D-Wave and its peers spark trading activity. This deep dive explains wha...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
Kadant is navigating 2025 with a mix of packaging strength and manufacturing headwinds. This guide breaks down what t...
As 2025 unfolds, MediWound faces a pivotal year for debt, cash, and milestones. This analysis breaks down what mediwo...
Palantir's quarterly results spotlight more than top-line growth. The real signal is how much existing customers are ...
When a chief executive sells stock after exercising options, investors often wonder if confidence underpins the move....
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
In the race to dominate AI-powered cloud services, Iren's ability rapidly scale data centers sets it apart. This arti...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...